Publications:
Bilen, M. A., Martini, D. J., Liu, Y., Shabto, J. M., Brown, J. T., Williams, M., Khan, A. I., Speak, A., Lewis, C., Collins, H., Kissick, H. T., Carthon, B. C., Akce, M., Shaib, W. L., Alese, O. B., Pillai, R. N., Steuer, C. E., Wu, C. S., Lawson, D. H., … Master, V. A. (2020). Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The Oncologist, 25(3), e528–e535.
Higgins, M. I., Martini, D. J., Patil, D. H., Nabavizadeh, R., Steele, S., Williams, M., Joshi, S. S., Narayan, V. M., Sekhar, A., Psutka, S. P., Ogan, K., Bilen, M. A., & Master, V. A. (2021). Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma. Cancer, 127(12), 1974–1983.
Khan, A. I., Psutka, S. P., Patil, D. H., Hong, G., Williams, M. A., Bilen, M. A., Sekhar, A., Kissick, H. T., Narayan, V. M., Joshi, S. S., Ogan, K., & Master, V. A. (2022). Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Cancer, 128(11), 2073–2084.
Li, J. L., Henderson, M. A., Revenig, L. M., Sweeney, J. F., Kooby, D. A., Maithel, S. K., Master, V. A., & Ogan, K. (2016). Frailty and one-year mortality in major intra-abdominal operations. The Journal of Surgical Research, 203(2), 507–512.e1.
Makhani, S. S., Kim, F. Y., Liu, Y., Ye, Z., Li, J. L., Revenig, L. M., Vaughan, C. P., Johnson, T. M., 2nd, García, P. S., Ogan, K., & Master, V. A. (2017). Cognitive Impairment and Overall Survival in Frail Surgical Patients. Journal of the American College of Surgeons, 225(5), 590–600.e1.
Midenberg, E., Higgins, M. I., Schmeusser, B. N., Patil, D. H., Zaldumbide, J., Martini, D. J., Steele, S., Williams, M., Nabavizadeh, R., Psutka, S. P., Ogan, K., Bilen, M. A., & Master, V. A. (2023). Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urologic Oncology, 41(1), 50.e19–e50.e26.
Revenig, L. M., Canter, D. J., Henderson, M. A., Ogan, K., Kooby, D. A., Maithel, S. K., Liu, Y., Kim, S., & Master, V. A. (2015). Preoperative quantification of perceptions of surgical frailty. The Journal of Surgical Research, 193(2), 583–589.
Revenig, L. M., Canter, D. J., Kim, S., Liu, Y., Sweeney, J. F., Sarmiento, J. M., Kooby, D. A., Maithel, S. K., Hill, L. L., Master, V. A., & Ogan, K. (2015). Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality. Journal of the American College of Surgeons, 220(5), 904–911.e1.
Revenig, L. M., Canter, D. J., Master, V. A., Maithel, S. K., Kooby, D. A., Pattaras, J. G., Tai, C., & Ogan, K. (2014). A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery. Journal of Endourology / Endourological Society, 28(4), 476–480.
Revenig, L. M., Canter, D. J., Taylor, M. D., Tai, C., Sweeney, J. F., Sarmiento, J. M., Kooby, D. A., Maithel, S. K., Master, V. A., & Ogan, K. (2013). Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. Journal of the American College of Surgeons, 217(4), 665–670.e1.
Schmeusser, B. N., Ali, A. A., Fintelmann, F. J., Garcia, J. M., Williams, G. R., Master, V. A., & Psutka, S. P. (2023). Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma. Current Urology Reports. https://doi.org/10.1007/s11934-023-01157-6
Schmeusser, B. N., & Master, V. A. (2023). The 5-factor frailty index for radical nephrectomy: Simplifying personalized preoperative risk-stratification. Urologic Oncology. https://doi.org/10.1016/j.urolonc.2023.05.007
Schmeusser, B. N., Midenberg, E., Palacios, A. R., Ali, A. A., Patil, D. H., Higgins, M., Nabavizadeh, R., Croll, B., Williams, M., Sheehy, J., Zheng, B., Narayan, V. M., Joshi, S. S., Ogan, K., Psutka, S. P., Bilen, M. A., & Master, V. A. (2023). Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2023.04.005
Schmeusser, B. N., Midenberg, E., Palacios, A. R., Vettikattu, N., Patil, D. H., Medline, A., Higgins, M., Armas-Phan, M., Nabavizadeh, R., Joshi, S. S., Narayan, V. M., Psutka, S. P., Ogan, K., Bilen, M. A., & Master, V. A. (2022). Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma. Frontiers in Oncology, 12, 1068357.